325 related articles for article (PubMed ID: 16836710)
1. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
Naccarelli GV
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
[No Abstract] [Full Text] [Related]
2. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
Zareba W
Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
[No Abstract] [Full Text] [Related]
3. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
4. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
5. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
6. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
[No Abstract] [Full Text] [Related]
7. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
8. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
9. Stabilizing and resuscitating patients with automatic implantable cardioverter-defibrillators.
Ellis JI
West J Med; 1993 Nov; 159(5):595-6. PubMed ID: 8279158
[No Abstract] [Full Text] [Related]
10. Multiple morphologies of ventricular tachycardia assessed by implantable cardioverter-defibrillator electrograms in a patient with Chagas disease, successfully treated with catheter ablation: modern problems, old solutions.
Hadid C; Gallino S; Di Toro D; Celano L; Lopez C; Duce E; Labadet C
Europace; 2012 Nov; 14(11):1660. PubMed ID: 22581623
[No Abstract] [Full Text] [Related]
11. A lifesaving jolt from within.
Johns Hopkins Med Lett Health After 50; 2003 Feb; 14(12):1-2. PubMed ID: 12619609
[No Abstract] [Full Text] [Related]
12. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
13. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillators: a guide for clinicians.
Davidson T; VanRiper S; Harper P; Wenk A
Heart Lung; 1994; 23(3):205-15; quiz 216-7. PubMed ID: 8039991
[TBL] [Abstract][Full Text] [Related]
15. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
Gerstenfeld EP
J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
[No Abstract] [Full Text] [Related]
17. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
Lou ZY; Zhou MH; Li XQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
[No Abstract] [Full Text] [Related]
18. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
19. Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm.
D'Aloia A; Faggiano P; Brentana L; Boldini A; Curnis A; Bontempi L; Dei Cas L
Int J Cardiol; 2005 Aug; 103(2):207-8. PubMed ID: 16080982
[No Abstract] [Full Text] [Related]
20. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
Singh S; Murawski MM
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
